2. Academic Validation
  3. Novel HDAC1 and HDAC2 Inhibitors for Treating Diseases

Novel HDAC1 and HDAC2 Inhibitors for Treating Diseases

  • ACS Med Chem Lett. 2021 Sep 21;12(10):1532-1533. doi: 10.1021/acsmedchemlett.1c00488.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Smith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia30309, United States.
PMID: 34676033 DOI: 10.1021/acsmedchemlett.1c00488
Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-139650
    98.05%, HDAC Inhibitor